Digital diagnostics company Paige.AI raises $100M in series C round

Artificial intelligence-based digital diagnostics company Paige.AI Inc. received $100 million in a series C financing round.

The round was led by Casdin Capital LLC and Johnson & Johnson's venture capital arm, Johnson & Johnson Innovation - JJDC Inc., with participation from current investors and other funds.

Paige.AI will use the fresh capital to boost its artificial intelligence-based clinical applications, biomarkers and diagnostics, as well as to invest in sales and marketing efforts to scale product adoption by hospitals and laboratories.

It also aims to use the funds to expand its engineering and commercial teams by hiring about 70 new workers in 2021.